BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28292623)

  • 1. Additive value of interleukin-6 and C-reactive protein in risk prediction for all-cause and cardiovascular mortality among a representative adult cohort in Taiwan.
    Lin YH; Glei D; Weinstein M; Wu SI; Chien KL
    J Formos Med Assoc; 2017 Dec; 116(12):982-992. PubMed ID: 28292623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of mortality risk in the elderly.
    Störk S; Feelders RA; van den Beld AW; Steyerberg EW; Savelkoul HF; Lamberts SW; Grobbee DE; Bots ML
    Am J Med; 2006 Jun; 119(6):519-25. PubMed ID: 16750966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoy receptor 3, a novel inflammatory marker, and mortality in hemodialysis patients.
    Hung SC; Hsu TW; Lin YP; Tarng DC
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1257-65. PubMed ID: 22626963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients.
    Panichi V; Maggiore U; Taccola D; Migliori M; Rizza GM; Consani C; Bertini A; Sposini S; Perez-Garcia R; Rindi P; Palla R; Tetta C
    Nephrol Dial Transplant; 2004 May; 19(5):1154-60. PubMed ID: 14993508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study.
    Tuomisto K; Jousilahti P; Sundvall J; Pajunen P; Salomaa V
    Thromb Haemost; 2006 Mar; 95(3):511-8. PubMed ID: 16525580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis.
    Li Y; Zhong X; Cheng G; Zhao C; Zhang L; Hong Y; Wan Q; He R; Wang Z
    Atherosclerosis; 2017 Apr; 259():75-82. PubMed ID: 28327451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of the interaction between short-term, metronome-paced heart rate variability, and inflammation: results from the population-based CARLA cohort study.
    Medenwald D; Swenne CA; Loppnow H; Kors JA; Pietzner D; Tiller D; Thiery J; Nuding S; Greiser KH; Haerting J; Werdan K; Kluttig A
    Europace; 2017 Jan; 19(1):110-118. PubMed ID: 27221352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between inflammatory biomarkers and all-cause, cardiovascular and cancer-related mortality.
    Singh-Manoux A; Shipley MJ; Bell JA; Canonico M; Elbaz A; Kivimäki M
    CMAJ; 2017 Mar; 189(10):E384-E390. PubMed ID: 27895145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of C-reactive protein and interleukin-6 in dialysis patients: a systematic review and meta-analysis.
    Zhang W; He J; Zhang F; Huang C; Wu Y; Han Y; Zhang W; Zhao Y
    J Nephrol; 2013; 26(2):243-53. PubMed ID: 22684644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRP level and HDL cholesterol concentration jointly predict mortality in a Korean population.
    Kim KI; Oh SW; Ahn S; Heo NJ; Kim S; Chin HJ; Na KY; Chae DW; Kim CH; Kim S
    Am J Med; 2012 Aug; 125(8):787-95.e4. PubMed ID: 22840665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.
    Sun J; Axelsson J; Machowska A; Heimbürger O; Bárány P; Lindholm B; Lindström K; Stenvinkel P; Qureshi AR
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1163-1172. PubMed ID: 27281698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation.
    Hijazi Z; Aulin J; Andersson U; Alexander JH; Gersh B; Granger CB; Hanna M; Horowitz J; Hylek EM; Lopes RD; Siegbahn A; Wallentin L;
    Heart; 2016 Apr; 102(7):508-17. PubMed ID: 26839066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation biomarkers and mortality prediction in patients with type 2 diabetes (ZODIAC-27).
    Landman GW; Kleefstra N; Groenier KH; Bakker SJ; Groeneveld GH; Bilo HJ; van Hateren KJ
    Atherosclerosis; 2016 Jul; 250():46-51. PubMed ID: 27179179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation of C-reactive protein levels to total and cardiovascular mortality in older U.S. women.
    Tice JA; Browner W; Tracy RP; Cummings SR
    Am J Med; 2003 Feb; 114(3):199-205. PubMed ID: 12637134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 as a first-rated serum inflammatory marker to predict mortality and hospitalization in the oldest old: A regression and CART approach in the BELFRAIL study.
    Adriaensen W; Matheï C; Vaes B; van Pottelbergh G; Wallemacq P; Degryse JM
    Exp Gerontol; 2015 Sep; 69():53-61. PubMed ID: 26051931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6, but not C-reactive protein, predicts the occurrence of cardiovascular events after drug-eluting stent for unstable angina.
    Chen SL; Liu Y; Lin L; Ye F; Zhang JJ; Tian NL; Zhang JX; Hu ZY; Xu T; Li L; Xu B; Latif F; Nguyen T
    J Interv Cardiol; 2014 Apr; 27(2):142-54. PubMed ID: 24588086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation.
    Aulin J; Siegbahn A; Hijazi Z; Ezekowitz MD; Andersson U; Connolly SJ; Huber K; Reilly PA; Wallentin L; Oldgren J
    Am Heart J; 2015 Dec; 170(6):1151-60. PubMed ID: 26678637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.